Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022
Thu, August 11, 2022
Wed, August 10, 2022

Matt O"Brien Maintained (APYX) at Buy with Increased Target to $12 on, Aug 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-12-on-aug-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matt O"Brien of Piper Sandler, Maintained "Apyx Medical Corporation" (APYX) at Buy with Increased Target from $6 to $12 on, Aug 12th, 2022.

Matt has made no other calls on APYX in the last 4 months.

There is 1 other peer that has a rating on APYX. Out of the 1 peers that are also analyzing APYX, 0 agree with Matt"s Rating of Hold.

This is the rating of the analyst that currently disagrees with Matt;

Kyle Bauser of "Lake Street" Maintained at Strong Buy with Increased Target to $17 on, Tuesday, July 19th, 2022


Publication Contributing Sources